Commercialisation Australia Round 5 Recipients

Twenty one Australian inventions will be turned into commercial success stories, with the support of the Commercialisation Australia Program.

Over $10 million will be invested in the projects through Commercialisation Australia, the Australian Government’s flagship initiative for Australian entrepreneurs.

Announcing the successful applicants, Innovation Minister Senator Kim Carr said he was pleased to help talented researchers and entrepreneurs capitalise on their good ideas.

In 2010, its first year of operation, Commercialisation Australia awarded a total of $33.6 million for 88 projects. See Round 3 recipients, Round 2 recipients and Round 1 recipients.

“Commercialisation Australia is achieving remarkable results for a large and diverse group of Australian companies and entrepreneurs.” Senator Carr said. “The opportunities we are opening will keep Australia powering ahead in the global knowledge economy.”

Applicant Grant Description
Harmoni Organics $45,233 Harmoni’s KISS is a holistic, organic and packaged approach to teen healthcare, coupled with effective, educational tools and strategies to support young teens and their parents make good choices through puberty. The company aims to become the first real educational challenger to current market leaders.

Funding from Commercialisation Australia will help Harmoni Organics gain the skills and knowledge to successfully commercialise Harmoni’s KISS.

Descrete Australia $248,520 Commercialisation Australia funding has been awarded to undertake laboratory testing and site trialling of Descrete’s cement additive to ensure compatibility with a US partner’s existing manufacturing infrastructure and local raw materials.

A successful trial will lead to a Heads of Agreement in regards to ongoing supply of DP201, moving to a full commercial supply arrangement.

13 Find Aggregation Services $888,459 13 Find is an innovative service connecting consumers and businesses across all main communication channels.

Funding from Commercialisation Australia will enable 13 FIND to roll-out its service to Australia’s Eastern seaboard of Australia through the scaling of its proprietary technology platform.

Posse Holdings $758,900 Posse Holdings has received Commercialisation Australia funding to undertake an early stage commercialisation project.

Posse.com will build its web platform capacity, acquire content supply partners and conduct market research and tests in order to successfully launch the platform in Australia, the US & UK

Virtual Ark $250,000 Virtual Ark is developing a management platform to enable the operation and management of enterprise level applications on public and private cloud computing infrastructure.

Funding from Commercialisation Australia will help Virtual Ark to engage an experienced executive and conduct proof of concept trials.

Sangraal $1,071,270 Sangraal has developed technology for manufacturing PET plastic bottles with a PET handle moulded into the bottle. For bottles in sizes of two litres and above, the PET Integral Handle Bottle offers significant improvement in consumer handling, process efficiency, cost effectiveness and end use recyclability against any alternative worldwide.

Funding from Commercialisation Australia will enable Sangraal to engage an experienced executive.

Medivations $150,000 Every year, tens of thousands of people die because of respiratory illnesses and chest infections. The usual method for self-clearing the lungs is to cough.

However many people can’t cough effectively because they are, for example, vegetative, sedated, in pain or unconscious.

Hospitals use suction to clear secretions, but the catheter cannot penetrate the lower airways, so only the uppermost lung is cleared. Medivations has developed the CoughStim which uses ultrasonic waves, applied externally to a patient’s neck to stimulate a cough reflex.

Funding from Commercialisation Australia will help Medivations to prove the concept to the health and medical sector including regulators and potential commercial partners.

Locatrix International $241,000 Locatrix International has developed a software platform which derives contextual information about a mobile phone user and uses the information to deliver data or services to a subscriber’s mobile phone.

Funding from Commercialisation Australia will help to support the development of the Locatrix Content Platform (LCP) and several pilot mobile applications.

Earth Sense $239,500 Earth Sense has developed a user friendly GPS field mapping software program which allows for the rapid mapping of environmental and geological attributes and public assets, allowing the user to continue mapping while staying on the move on foot, in a 4-wheel drive, boat or aircraft.

The software is applicable to industries such as mining, power supply, environmental management, local councils and other government bodies that require field mapping. Commercialisation Australia will help

Earth Sense to undertake a proof of concept project for its software.

Euclideon $1,984,652 Most 3D technology is created for computer games using (angular) polygons. Euclideon has developed what may prove a groundbreaking advance in 3D technology, creating a search algorithm that will result in 3D images with vastly higher geometry – while saving costs and offering greater portability between platforms.

It will have benefits for architecture, games, mining the sciences and many other industries.

Funding from Commercialisation Australia will support programmers to convert the system from PC to game consoles, mobile phones and other platforms.

Seasafe $121,200 Seasafe has developed a self-contained manoverboard & lost-diver alarm, tracking and location system. The technology combines cutting edge engineering with advanced Radio Frequency signal tracking techniques. It immediately alerts vessel

skippers/controllers of a Man-Overboard or Lost – Diver incident and continues to transmit the distress signal for up to 7 days.

The technology allows for an instant response to marine emergencies at vessel level without unnecessarily invoking the services of traditional Search and Rescue authorities.

Funding provided by Commercialisation Australia will help Seasafe engage an experienced executive to internationally commercialise and leverage its

product.

Florey Neuroscience $50,000 Neurodegenerative diseases caused by dementia are a massive burden on the community. Dr Siew Yeen Chai from the Florey Neuroscience Institute is on the way to developing and refining a new drug to treat learning and memory loss, especially in dementia patients.

Funding assistance from Commercialisation Australia will facilitate collaboration between the Florey Neuroscience Institute and a biopharma company to further develop this work.

Termite Solutions Victoria $50,000 Current construction methods require termite barriers and concrete expansion materials to be installed separately by different operators at different times which delays overall construction workflow.

Termite Solutions Victoria has invented Greenzone, a termite barrier which integrates a compressible foam substrate with a termiticide, delivering significant savings in labour and materials.

Funding provided by Commercialisation Australia will help Termite Solutions Victoria to commercialise its product.

Affinity Biosciences $48,450 Encapsulated display (EcD) is a proprietary protein display platform capable of rapidly evolving custom proteins, and is applicable to fields as diverse as industrial enzyme production and the production of therapeutic antibodies.

Funding from Commercialisation Australia will assist Affinity Biosciences to engage industry experts in business plan development and execution, identifying EcD’s optimal first implementation and potential commercial partners.

Agent Oriented Software $235,000 The recent BP drilling rig disaster has heightened awareness of the need for intelligent, critical decision making drilling control systems that are not subject to human error.

Agent Oriented Software has developed the Hydrate – Intelligent Watchdog (H-iWD) to assist and advise the operators of risks during oil drilling and extraction.

Funding from Commercialisation Australia will enable Agent Oriented Software to develop a working prototype of the H-iWD.

Planet Innovation $228,081 Planet Innovation has developed a hot water system with significantly increased efficiency through the use of solar heated air to assist in heating the water.

The system utilises heat pumps that source their energy from solar heated air in roof cavities.

This invention has a much lower carbon footprint than existing hot water systems, with a demonstrated reduction in energy use of up to 50%.

Funding from Commercialisation Australia will help Planet Innovation to complete verification, preparation for manufacturing and commercial launch of the heat pump.

Advent Pharmaceuticals $1,295,715 Advent Pharmaceuticals has developed a novel inhaler which can compete with proprietary products, to provide a lower priced alternative for governments, insurers and patients.

Funding from Commercialisation Australia will help take Advent’s novel inhaler ‘g60’ through late stage development and regulatory milestones to commercialisation.

Optimatics Solutions $250,000 A problem plaguing water management is the cost effective movement of water from one place to another. Optimatics has produced optimisation software, the Water Supply System Optimisation Tool (WSS), to address the problem.

Funding from Commercialisation Australia will help Optimatics Solutions to create a fully-functional software product ready for purchase by water utilities to help generate savings of 10% or more in operational and capital expenditure.

Alcidion Corporation $1,475,910 Traditional hospital software has focused primarily on capturing data about patients but it does not provide real-time clinical decision-making capability.

Alcidion Corporation has developed a new generation Intelligent Record (iR) that provides realtime clinical analysis to deliver high performance hospital services and health care. With the help of the system, care teams will be able to provide safer patient care, more quickly, at less cost.

Funding from Commercialisation Australia will help Alcidion Corporation to commercialise the product.

AQ1 Systems $235,000 AQ1 Systems has developed a shrimp feeding control system which matches shrimp appetite precisely with feed delivery. This system optimises growth and food utilisation, minimises the environmental impacts of shrimp farming and improves labour efficiency.

Success will result in a market leading position in feeding control technology for the $25b global shrimp industry.

Funding from Commercialisation Australia will help AQ1 conduct proof of concept trials for the system.

300K Enterprises $250,000 Outdoor lights on industrial sites and public street lights typically take 2-4 hours to replace, in addition to requiring power isolation and the risks associated with working at height for long hours. 300K Enterprises has developed new energy and labour saving light fittings for industrial and commercial use.

The invention enables outdoor industrial lights to be replaced without switching off the power and can reduce replacement time to less than 30 minutes. These innovative lighting products will mean large savings in maintenance and operating costs, reduced greenhouse gas emissions and greatly improved safety for customers in industrial markets.

Funding from Commercialisation Australia will help 300K Enterprises to support the later stage development and commercialisation of the product.

Total $10,116,890

We are specialists in preparing and winning government grants. If you require assistance with a government grant application please contact us to discuss further.

2018-11-25T20:43:50+00:00March 8th, 2011|